Thema
Antibodies, Monoclonal, Humanized
29.587
Journal Article
25.319
Antibodies, Monoclonal
10.941
Research Support, Non-U.S. Gov't
9.853
Review
5.387
Bevacizumab
5.360
2S9ZZM9Q9V
5.351
Case Reports
4.721
Antineoplastic Agents
4.463
Angiogenesis Inhibitors
4.347
EC 2.7.10.1
3.912
Letter
2.995
Randomized Controlled Trial
2.835
Multicenter Study
2.796
Trastuzumab
2.682
P188ANX8CK
2.676
Vascular Endothelial Growth Factor A
2.554
Adalimumab
2.265
FYS6T7F842
2.252
Receptor, ErbB-2
2.068
Comment
1.967
Research Support, N.I.H., Extramural
1.953
Cetuximab
1.866
PQX0D8J21J
1.854
Antirheumatic Agents
1.817
Comparative Study
1.812
pembrolizumab
1.754
DPT0O3T46P
1.743
Tumor Necrosis Factor-alpha
1.732
tocilizumab
1.654
I031V2H011
1.652
Clinical Trial, Phase II
1.618
Immunosuppressive Agents
1.528
Ranibizumab
1.515
ZL1R02VT79
1.513
VEGFA protein, human
1.348
ERBB2 protein, human
1.274
Immunoglobulin G
1.267
ErbB Receptors
1.232
Infliximab
1.216
B72HH48FLU
1.206
Antineoplastic Agents, Immunological
1.130
Clinical Trial, Phase III
1.119
Anti-Inflammatory Agents
1.053
Fluorouracil
1.030
U3P01618RT
1.030
Biomarkers, Tumor
911
eculizumab
906
A3ULP0F556
903
Clinical Trial, Phase I
886
mehr ...